(Q39293104)

10 September 2017

title

An indispensable role of CPT-1a to survive cancer cells during energy stress through rewiring cancer metabolism (English)

1 reference

10 September 2017

Jingtao Luo

1

1 reference

10 September 2017

Yun Hong

2

1 reference

10 September 2017

Xiaoan Tao

3

1 reference

10 September 2017

Xi Wei

4

1 reference

10 September 2017

Lun Zhang

5

1 reference

10 September 2017

Qiang Li

6

1 reference

10 September 2017

publication date

13 October 2016

1 reference

10 September 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-016-5382-6

10 September 2017

exact match

0 references

cites work

Regulation of cancer cell metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Tumor suppressors and cell metabolism: a recipe for cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Tumor cell metabolism: an integral view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Cancer metabolism: fatty acid oxidation in the limelight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Inhibitory effects of sea buckthorn procyanidins on fatty acid synthase and MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Silencing ECHS1 attenuates the proliferation and induces the autophagy of hepatocellular carcinoma via impairing cell metabolism and activating AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Inhibition of AMP-Activated Protein Kinase at the Allosteric Drug-Binding Site Promotes Islet Insulin Release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Epidemiological-molecular evidence of metabolic reprogramming on proliferation, autophagy and cell signaling in pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Challenges of cancer therapy with natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Significantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5382-6

Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27739027

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-016-5382-6

0 references

1 reference